For anyone questioning whether GLP-1 therapy is worth it, these shared experiences demonstrate how life-changing MEDVi can be
Indeed, GLP-1 agonists appear to be helpful for gastrointestinal diseases such as IBS, ulcerative colitis, and Crohns disease
This damage was ameliorated by spermidine supplementation, which reduced inflammation, decreased antibody production and increased vascular relaxation and mitophagy (Reference Kim and Massett87)
For example, following the induction of intestinal ischemia in humans, a rapid increase in GLP-1 secretion was observed, suggesting a link between endogenous LPS translocation and GLP-1 activation under conditions of barrier dysfunction (Lebrun et al., 2017)
The role of GLP-1R in type 2 diabetes mellitus (T2DM) is highlighted, emphasizing its pivotal contribution to glucose homeostasis, promoting -cell proliferation, and facilitating insulin release